Shareholders to Vote on Change in Use of IPO Proceeds at Next Shanghai Fudan-Zhangjiang Bio-Pharmaceutical EGM
I'm PortAI, I can summarize articles.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. will hold an extraordinary general meeting to vote on a proposal to change the use of proceeds from its A share IPO. The proposal seeks to reallocate unused funds to a new project, extending the utilization timeline to December 31, 2027. The board recommends voting in favor of this proposal.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments